AR072141A1 - Composicion nutricional para lactantes nacidos por cesarea - Google Patents

Composicion nutricional para lactantes nacidos por cesarea

Info

Publication number
AR072141A1
AR072141A1 ARP090102156A ARP090102156A AR072141A1 AR 072141 A1 AR072141 A1 AR 072141A1 AR P090102156 A ARP090102156 A AR P090102156A AR P090102156 A ARP090102156 A AR P090102156A AR 072141 A1 AR072141 A1 AR 072141A1
Authority
AR
Argentina
Prior art keywords
oligosacids
milk
casein
hydrolyzate
infants
Prior art date
Application number
ARP090102156A
Other languages
English (en)
Inventor
Joachim Schmitt
Emmanuel Perrin
Gunther Boehm
Bernd Stahl
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/NL2008/050375 external-priority patent/WO2009151315A1/en
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of AR072141A1 publication Critical patent/AR072141A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/017—Hydrolysed proteins; Derivatives thereof from animals from blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pediatric Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Metodos para alimentar lactantes nacidos por ces rea y composiciones para administrar a dichos lactantes y en particular, uso de un producto obtenido por fermentacion de leche, suero, prote¡nas sericas, hidrolizado de prote¡nas sericas, case¡na, hidrolizado de case¡na y/o lactosa con bacterias que producen  cido l ctico. De esta forma es posible estimular una colonizacion r pida de la microbiota intestinal en dichos lactantes. Reivindicacion 1: Una composicion nutricional que comprende a) un producto derivado de la leche, donde dicho producto derivado de la leche es un sustrato basado en leche que es fermentado por bacterias productoras de  cido l ctico, donde dicho sustrato basado en leche comprende al menos uno seleccionado del grupo que consiste en leche, suero, prote¡nas sericas, hidrolizado de prote¡nas sericas, case¡na, hidrolizado de case¡na y/o lactosa; b) menos de 103 cfu de bacterias productoras de  cido l ctico por g de peso seco de la composicion; y c) al menos dos oligosac ridos no digeribles seleccionados del grupo que consiste en fructo-oligosac ridos, galacto-oligosac ridos, gluco-oligosac ridos, arabino-oligosac ridos, manano-oligosac ridos, xilo-oligosac ridos, fuco-oligosac ridos, arabinogalacto-oligosac ridos, glucomano-oligosac ridos, galactomano-oligosac ridos, oligosac ridos que comprenden  cido si lico y oligosac ridos que comprenden  cido uronico; para usar en el suministro de nutricion a un lactante nacido por ces rea.
ARP090102156A 2008-06-13 2009-06-12 Composicion nutricional para lactantes nacidos por cesarea AR072141A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2008/050375 WO2009151315A1 (en) 2008-06-13 2008-06-13 Nutritional composition for infants delivered via caesarean section
EP08168054 2008-10-31

Publications (1)

Publication Number Publication Date
AR072141A1 true AR072141A1 (es) 2010-08-11

Family

ID=40935729

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP090102157A AR072142A1 (es) 2008-06-13 2009-06-12 Nutricion para prevenir infecciones.proceso. composicion. uso.
ARP090102151A AR078014A1 (es) 2008-06-13 2009-06-12 Proceso para la fabricacion de una composicion nutricional estimuladora del sistema inmune
ARP090102156A AR072141A1 (es) 2008-06-13 2009-06-12 Composicion nutricional para lactantes nacidos por cesarea

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ARP090102157A AR072142A1 (es) 2008-06-13 2009-06-12 Nutricion para prevenir infecciones.proceso. composicion. uso.
ARP090102151A AR078014A1 (es) 2008-06-13 2009-06-12 Proceso para la fabricacion de una composicion nutricional estimuladora del sistema inmune

Country Status (13)

Country Link
US (5) US20110182934A1 (es)
EP (4) EP2293677B1 (es)
CN (3) CN102065867A (es)
AR (3) AR072142A1 (es)
BR (1) BRPI0915149B1 (es)
DK (1) DK2285387T3 (es)
ES (2) ES2558960T3 (es)
HU (1) HUE028390T2 (es)
PL (2) PL2285387T3 (es)
PT (1) PT2285387E (es)
RU (2) RU2543634C2 (es)
SI (1) SI2285387T1 (es)
WO (3) WO2009151329A1 (es)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009072889A1 (en) 2007-12-07 2009-06-11 N.V. Nutricia Bifidobacterium for dust mite allergy
CN102065867A (zh) 2008-06-13 2011-05-18 N.V.努特里奇亚 预防感染的营养物
CA2761444C (en) 2009-05-11 2018-04-24 Nestec S.A. Lactobacillus johnsonii la1 ncc533 (cncm i-1225) and immune disorders
WO2011121379A1 (en) * 2010-03-30 2011-10-06 Assistance Publique - Hopitaux De Paris Use of bifidobacteria for preventing allergy in breastfed infants
WO2011148221A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Lactic acid bacteria for maturation of the enteric nervous system in infants
EP3097791B1 (en) * 2010-06-04 2018-05-16 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
WO2011150949A1 (en) * 2010-06-04 2011-12-08 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
KR101757504B1 (ko) * 2010-06-28 2017-07-12 가부시키가이샤 야쿠르트 혼샤 경구용 피부 성상 개선제
WO2012057636A1 (en) * 2010-10-27 2012-05-03 Fonterra Corporate Research And Development Limited Modulation of th1 and th2 immune response by lactic acid whey
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
AU2011328041A1 (en) * 2010-11-11 2013-05-23 Nestec S.A. Spoonable yogurt preparations containing non-replicating probiotic micro-organisms
RU2593716C2 (ru) * 2010-11-11 2016-08-10 Нестек С.А. Замороженные кондитерские изделия, содержащие пробиотические микроорганизмы
EP2465508A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
WO2012078030A1 (en) * 2010-12-06 2012-06-14 N.V. Nutricia Fermented infant formula
EP2520181A1 (en) * 2011-05-02 2012-11-07 N.V. Nutricia Fermented infant formula
BR112013013777B1 (pt) * 2010-12-06 2019-10-29 Nutricia Nv método não terapêutico e composição nutricional para bebês
WO2012078032A1 (en) 2010-12-10 2012-06-14 N.V. Nutricia Early stimulation of taste and/or flavour acceptance
EP3335576A1 (en) * 2010-12-31 2018-06-20 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
PL2481299T3 (pl) 2011-01-31 2017-09-29 Synformulas Gmbh Szczepy bifidobacterium bifidum do stosowania w chorobach przewodu pokarmowego
MY182335A (en) 2011-07-22 2021-01-19 Abbott Lab Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
WO2013053073A1 (zh) * 2011-10-10 2013-04-18 Huang Daiyong 一种基于甘露寡糖的胃肠道健康因子组合物
WO2013187755A1 (en) * 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
US9974816B2 (en) * 2012-11-02 2018-05-22 N.V. Nutricia Synbiotics combination for brain improvement
CA3012383C (en) 2013-02-28 2021-03-02 Teewinot Technologies Limited Biosynthesis of cannabinoids
US9352020B2 (en) * 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US20140271978A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Low-buffer nutritional compositions and uses thereof
WO2014168474A1 (en) * 2013-04-08 2014-10-16 N.V. Nutricia Fermented nutritional composition with thiol protease inhibitor
WO2014200334A1 (en) * 2013-06-14 2014-12-18 N.V. Nutricia Synbiotic composition for treatment of infections in allergic patients
CN104413334A (zh) * 2013-08-30 2015-03-18 深圳华大基因科技有限公司 可食用组合物及其制备方法和用途
EP2857410A1 (en) 2013-10-04 2015-04-08 Jennewein Biotechnologie GmbH Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
AU2014350144B2 (en) 2013-11-15 2019-11-21 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of URT infections in infants or young children at risk
EP3082473A2 (en) * 2013-12-19 2016-10-26 Nestec S.A. Nutritional composition to reduce metabolic stress in infants
CA2959283A1 (en) 2014-08-25 2016-03-03 Full Spectrum Laboratories Limited Apparatus and methods for the simultaneous production of cannabinoid compounds
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
WO2017043962A1 (en) * 2015-09-11 2017-03-16 N.V. Nutricia Method for stimulating microbiota health after non-natural birth
EP3150257A1 (en) * 2015-09-30 2017-04-05 Buga, Doris A method for producing a composition for strengthening the immune system
CN105341938B (zh) * 2015-10-10 2018-06-26 北京康比特体育科技股份有限公司 一种降低大强度运动后呼吸道感染率的保健食品
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
WO2017114901A1 (en) * 2015-12-29 2017-07-06 N.V. Nutricia Nutritional formula with non-digestible oligosaccharides and non-replicating lactic acid producing bacteria
BR112018013501B1 (pt) * 2015-12-29 2022-12-20 N.V. Nutricia Uso de um ingrediente fermentado e oligossacarídeo não digerível
WO2017194607A1 (en) 2016-05-10 2017-11-16 N.V. Nutricia Fermented infant formula
CN109475165A (zh) 2016-05-10 2019-03-15 N·V·努特里奇亚 发酵的婴儿配方物
CA3036494C (en) * 2016-09-30 2022-10-18 The A2 Milk Company Limited Beta-caseins and gut microbiota
CN110573164B (zh) * 2017-03-08 2023-09-29 N·V·努特里奇亚 用于减轻鼻上皮炎症的含有不可消化的低聚糖的组合物
AU2018295414A1 (en) * 2017-07-07 2020-01-16 Societe Des Produits Nestle S.A. Human milk fortifier
CN107397230A (zh) * 2017-08-21 2017-11-28 杭州特悘衡康生物科技有限公司 营养组合物、促进手术后肌肉恢复和蛋白质合成的配方食品及其应用
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
EP3723778A1 (en) * 2017-12-11 2020-10-21 N.V. Nutricia Composition for use for treating delayed colonization by bifidobacterium after birth
CN111698993A (zh) 2018-02-09 2020-09-22 N·V·努特里奇亚 含有不可消化寡糖的发酵配方物
EP3749329A1 (en) 2018-02-09 2020-12-16 N.V. Nutricia Fermented formula with non-digestible oligosaccharides
ES2940808T3 (es) 2019-01-16 2023-05-11 Nutricia Nv Preparado fermentado con oligosacáridos no digeribles para su uso en infecciones inducidas por rotavirus
CN113423288A (zh) * 2019-02-04 2021-09-21 N·V·努特里奇亚 用于睡眠改善的含有不可消化的低聚糖的发酵配方物
CN113163835A (zh) 2019-05-15 2021-07-23 N·V·努特里奇亚 促进肠道发育的发酵配方物
US20220248739A1 (en) * 2019-05-29 2022-08-11 N.V. Nutricia Non-digestible oligosaccharides for decreased colonic protein fermentation
PL3883393T3 (pl) 2019-06-04 2023-01-09 N.V. Nutricia Kompozycja żywieniowa zawierająca 2'fukozylolaktozę i dietetyczny maślan
US20220110985A1 (en) 2019-06-04 2022-04-14 N.V. Nutricia Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose
CN110839698A (zh) * 2019-11-29 2020-02-28 内蒙古伊利实业集团股份有限公司 一种组合物及其食品用途
GB2608587A (en) * 2021-06-25 2023-01-11 Mjn Us Holdings Llc Use of extensively hydrolysed protein

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110476A (en) 1977-01-10 1978-08-29 Johnson/Rhodes Cultured Foods, Inc. Preparation of liquid and frozen yogurt products
RU2031586C1 (ru) * 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
FR2723963B1 (fr) * 1994-08-31 1997-01-17 Gervais Danone Co Preparation de produits fermentes par streptococcus thermophilus, enrichis en galacto-oligosaccharides et en beta-galactosidase
EP1020123A1 (en) 1999-01-18 2000-07-19 Sitia-Yomo S.p.A. Beverages containing live lactic bacteria
FR2795917B1 (fr) * 1999-07-06 2001-08-31 Gervais Danone Sa Procede de preparation d'un produit lacte immunostimulant et ses applications
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
ES2232591T3 (es) 2000-03-01 2005-06-01 Societe Des Produits Nestle S.A. Formulacion de hidratos de carbono (adyuvante prebiotico) para la mejora de la respuesta inmune.
EP1145643A1 (en) 2000-04-10 2001-10-17 Phillip Connolly Improved milk protein concentrate
US7431939B1 (en) 2000-09-28 2008-10-07 Mississippi State University Inhibition of systemic infections in humans and vertebrates by dietary fibers
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
RU2220579C1 (ru) * 2002-07-31 2004-01-10 Зенович Сергей Михайлович Пищевой преимущественно кисломолочный продукт и закваска для его получения (варианты)
AU2003282494A1 (en) * 2002-10-11 2004-05-04 Wyeth Nutritional formulations containing synbiotic substances
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
US20050180962A1 (en) * 2003-01-30 2005-08-18 Eyal Raz Inactivated probiotic bacteria and methods of use thereof
FR2853908B1 (fr) * 2003-04-16 2005-06-03 Gervais Danone Sa Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
FR2857026B1 (fr) 2003-04-16 2012-11-16 Gervais Danone Sa Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
PL1638416T3 (pl) 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
EP2123282A3 (en) 2003-10-24 2010-01-20 N.V. Nutricia Immunemodulating oligosaccharides
DK1675481T3 (da) * 2003-10-24 2009-01-19 Nutricia Nv Synbiotisk præparat til börn
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
ES2359573T3 (es) 2004-12-27 2011-05-24 Nestec S.A. Empleo de una fórmula para bebes con un reducido contenido en proteínas.
US8591981B2 (en) * 2005-02-21 2013-11-26 Nestec S.A. Oligosaccharide mixture
ES2702631T5 (es) * 2005-02-28 2023-03-22 Nutricia Nv Composición nutricional con prebióticos y probióticos
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US20090156550A1 (en) 2005-12-06 2009-06-18 Potappel-Van T Land Belinda Composition containing oligosaccharides for the treatment/prevention of infections
EP1993384A2 (en) 2006-01-11 2008-11-26 Attune Foods Probiotic food, process for its preparation and dietary regimen
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
CN102065867A (zh) 2008-06-13 2011-05-18 N.V.努特里奇亚 预防感染的营养物
WO2010008272A1 (en) 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
WO2010070613A2 (en) 2008-12-18 2010-06-24 University College London Baby feeding formula and system
WO2012078030A1 (en) 2010-12-06 2012-06-14 N.V. Nutricia Fermented infant formula
EP2520181A1 (en) 2011-05-02 2012-11-07 N.V. Nutricia Fermented infant formula
BR112013013777B1 (pt) 2010-12-06 2019-10-29 Nutricia Nv método não terapêutico e composição nutricional para bebês
MX2011007872A (es) 2011-07-26 2013-01-29 Nucitec Sa De Cv Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento.

Also Published As

Publication number Publication date
EP3326633A1 (en) 2018-05-30
BRPI0915149A2 (pt) 2015-08-04
DK2285387T3 (en) 2016-01-25
ES2558960T3 (es) 2016-02-09
US20110182934A1 (en) 2011-07-28
AR078014A1 (es) 2011-10-12
HUE028390T2 (en) 2016-12-28
US20170173104A1 (en) 2017-06-22
EP2293677A1 (en) 2011-03-16
PL2285387T3 (pl) 2016-03-31
CN102118976B (zh) 2014-02-26
US20110097437A1 (en) 2011-04-28
PL2293677T3 (pl) 2018-05-30
BRPI0915149B1 (pt) 2018-02-14
WO2009151330A1 (en) 2009-12-17
SI2285387T1 (sl) 2016-02-29
PT2285387E (pt) 2016-02-09
EP2285387A1 (en) 2011-02-23
EP2285387B1 (en) 2015-10-14
US20110117077A1 (en) 2011-05-19
RU2543634C2 (ru) 2015-03-10
CN102123715A (zh) 2011-07-13
EP2293803A1 (en) 2011-03-16
US20170296563A1 (en) 2017-10-19
CN102065867A (zh) 2011-05-18
EP2293677B1 (en) 2017-11-15
AR072142A1 (es) 2010-08-11
RU2498605C2 (ru) 2013-11-20
RU2011100828A (ru) 2012-07-20
RU2011100829A (ru) 2012-07-20
US10124016B2 (en) 2018-11-13
CN102118976A (zh) 2011-07-06
WO2009151329A1 (en) 2009-12-17
WO2009151331A1 (en) 2009-12-17
ES2656776T3 (es) 2018-02-28
CN102123715B (zh) 2014-12-17

Similar Documents

Publication Publication Date Title
AR072141A1 (es) Composicion nutricional para lactantes nacidos por cesarea
ES2342625T3 (es) Mezcla de oligosacaridos.
WO2010133472A3 (en) Growing up milks containing probiotic micro-organisms
WO2010103140A3 (es) Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
JP2008529547A5 (es)
FI20115156A0 (fi) Maitopohjainen tuote ja menetelmä sen valmistamiseksi
RU2013128573A (ru) Композиция для лечения заболеваний кожи, включающая гидролизованные белки и олигосахариды
RU2259747C2 (ru) Штамм bifidobacterium, способ получения иммуностимулирующего молочного продукта и продукт, полученный этим способом
CA2839797A1 (en) Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
CY1111124T1 (el) Βητα-γαλακτοζιδαση με διαγαλακτοζυλιωτικη δραστηριοτητα
BR112014000322A2 (pt) "probióticos, e seus usos"
WO2011050426A3 (en) New strains of lactic acid bacteria and their combinations producing probiotic preparations
RU2011123651A (ru) Бактерии, продуцирующие сиаловую кислоту
MY168203A (en) Bioconversion of milk with bifidobacterium breve for treatment of allergic manifestations in infants
CA2817217A1 (en) Powdered cereal compositions comprising non-replicating probiotic microorganisms
CN106509130A (zh) 一种低敏新生儿配方乳粉及其制备方法
BR112015028164A2 (pt) probióticos e métodos de uso
BR112014009984B1 (pt) Método de preparação para glúten de milho fermentado para alimento com um teor de proteína aumentado comparado com a fermentação anterior
BRPI0704197A (pt) métodos para fabricar uma composição de produto de laticìnio, uma composição de laticìnio e um produto de queijo fresco
AR078388A1 (es) Producto lacteo pasteurizado y fermentado, y procedimiento para su preparacion
RU2008114558A (ru) Композиция для получения молочно-белкового биококтейля
Dushkova et al. Physicochemical, microbiological, and sensory characteristics of probiotic Bulgarian yoghurts obtained by ultrafiltration of goat’s milk
MY169478A (en) Nutritional composition for infants delivered via caesarean section
WO2014122175A1 (en) Composition comprising lactobacillus and a carrier
TH128841B (th) องค์ประกอบทางโภชนาการสำหรับทารกที่คลอดโดยผ่านทางการผ่าท้องทำคลอด

Legal Events

Date Code Title Description
FB Suspension of granting procedure